Mark K Oki Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark K Oki.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark K Oki. Mark K Oki is Chief Financial Officer & CAO in VIVUS INC ($VVUS) and SVP, CFO, CAO in VIVUS INC ($VVUS) and SVP, CFO and Sec in Alexza Pharmaceuticals Inc. ($ALXA) and SVP, Finance, CFO & Sec in Alexza Pharmaceuticals Inc. ($ALXA) and VP Fin Controller PAO PFO Sec in Alexza Pharmaceuticals Inc. ($ALXA) and VP Fin, Controller & PAO in Alexza Pharmaceuticals Inc. ($ALXA).
Latest Insider Trading Transactions of Mark K Oki
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2020 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 2.21 | 32,000 | 70,720 | 32,000 | |
| Nov 18 2019 | VVUS | VIVUS INC | Oki Mark K | SVP, CFO, CAO | Grant | A | 2.38 | 700 | 1,666 | 12,100 | 11.4 K to 12.1 K (+6.14 %) |
| Nov 18 2019 | VVUS | VIVUS INC | Oki Mark K | SVP, CFO, CAO | Grant | A | 2.38 | 700 | 1,666 | 12,100 | 11.4 K to 12.1 K (+6.14 %) |
| Jan 25 2019 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 4.05 | 32,000 | 129,600 | 32,000 | |
| Nov 16 2018 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Grant | A | 2.71 | 700 | 1,897 | 10,700 | 10 K to 10.7 K (+7.00 %) |
| Nov 07 2018 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Buy | P | 4.07 | 10,000 | 40,700 | 10,000 | 0 to 10 K |
| May 02 2018 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 0.37 | 200,000 | 74,000 | 200,000 | |
| Feb 06 2018 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 0.40 | 350,000 | 140,000 | 350,000 | |
| Jan 31 2017 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 1.12 | 385,000 | 431,200 | 385,000 | |
| Jan 26 2016 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 1.06 | 93,500 | 99,110 | 93,500 | |
| Nov 03 2015 | VVUS | VIVUS INC | Oki Mark K | Chief Financial Off ... | Option Exercise | A | 1.26 | 225,000 | 283,500 | 225,000 | |
| Jul 24 2015 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, Finance, CFO & ... | Option Exercise | A | 1.08 | 125,000 | 135,000 | 125,000 | |
| Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 4.42 | 87,500 | 386,750 | 87,500 | |
| Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Grant | A | 4.42 | 43,750 | 193,375 | 49,538 | 5.8 K to 49.5 K (+755.87 %) |
| Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Sell | S | 4.14 | 10,000 | 41,364 | 3,788 | 13.8 K to 3.8 K (-72.53 %) |
| Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
| Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 3.47 | 10,000 | 34,700 | 10,000 | |
| Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin Controller P ... | Sell | S | 0.34 | 31,873 | 10,776 | 137,896 | 169.8 K to 137.9 K (-18.77 %) |
| May 14 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin Controller P ... | Grant | A | 0.00 | 100,000 | 0 | 169,769 | 69.8 K to 169.8 K (+143.33 %) |
| Mar 26 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin Controller P ... | Grant | A | 0.00 | 31,873 | 0 | 69,769 | 37.9 K to 69.8 K (+84.11 %) |
| Aug 01 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.53 | 110,000 | 168,300 | 110,000 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 26,667 | 32,800 | 26,667 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 2.38 | 40,000 | 95,200 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 4,882 | 6,005 | 4,882 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 2.81 | 7,323 | 20,578 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 3,750 | 4,613 | 3,750 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 4.35 | 7,500 | 32,625 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 359 | 442 | 359 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 7.50 | 1,434 | 10,755 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 159 | 196 | 159 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 11.70 | 636 | 7,441 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | A | 1.23 | 5,000 | 6,150 | 5,000 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin, Controller ... | Option Exercise | D | 8.92 | 20,000 | 178,400 | 0 |
Page: 1